Clinical Trials Browser

Phase 2 × Solid Tumors × Methotrexate × Clear all

NCT05522582 2024-10-26

Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumors